Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey: Frequency, outcomes, and risk factor analysis

Journal of Pediatric Ophthalmology and Strabismus

Volumn 45, Issue 5, 2008, Pages 291-298

  Mutlu, Fatih Mehmet ^a   Altinsoy, H Ibrahim ^a   Mumcuoglo, Tarkan ^a   Kerimoglu, Hürkan ^b   Kiliç, Selim ^a   Kul, Mustafa ^a   Sarici, S Ümit ^a   Alpay, Faruk ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLOOD TRANSFUSION; CRYOTHERAPY; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; OUTCOME ASSESSMENT; OXYGEN THERAPY; RETROLENTAL FIBROPLASIA; RISK FACTOR; SEPSIS; TERTIARY HEALTH CARE; TURKEY (REPUBLIC); RETROSPECTIVE STUDY; STATISTICS;

BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; NEONATAL SCREENING; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 56049105407     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/01913913-20080901-12     Document Type: Article

References (46)

1. Terry TL. Extreme prematurity land fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol. 1942;24:203-204.
2. Kinsey VE, Arnold HJ, Kalina RE, et al. PaO2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics. 1977;60:655-668.
3. Ashton N, Ward B, Serpell G. Role of oxygen in the genesis of retrolental fibroplasia: a preliminary report. Br J Ophthalmol. 1953:37:513-520.
4. Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolencal fibroplasia. Pediatrics. 1980;65:1096-100.
5. Lucey JF, Dangman B. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics. 1984;73:82-96.
6. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991;98:1628-1640.
7. Reynolds JD, Dobson V, Quinn GE, et al. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arcb Ophthalmol. 2002;120:1470-1476.
8. Section on Ophthalmology American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006;117:572-576. Erratum in: Pediatrics. 2006;118:1324.
9. Joint Working Party of the Royal College of Ophthalmologists and British Association of Perinatal Medicine. Retinopathy of prematurity: guidelines for screening and treatment. Early Hum Dev. 1996;46:239-258.
10. Lang DM, Blackledge J, Arnold RW. Is Pacific race a retinopathy of prematurity risk factor? Arch Pediatr Adolesc Med. 2005;159:771-773.
11. Phan MH, Nguyen PN, Reynolds JD. Incidence and severity of retinopathy of prematurity in Vietnam, a doveloping middle-income country. J Pediatr Ophthalmol Strabismus. 2003;40:208-212.
12. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;12:1130-1134.
13. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II. Arch Ophthalmol. 1987;105:906-912. Erraturn in: Arch Ophthalmol. 1987;105:1498.
14. Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinoparhy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115:e518-e525.
15. American Academy of Pediatrics, Section on Ophthalmology. Screening examinations of premature infants for retinopathy of prematurity. Pediatrics. 2001;108:809-811.
16. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of Early Treatment for Retinopathy of Prematurity Randomized Trial. Arch Ophthalmol. 2003;121:1684-1694.
17. Schaffer DB, Palmer EA, Plotskv DF, et al. Prognoscic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993;100:230-237.
18. Maheshwari R, Kumar H, Paul VK, Singh M, Deorari AK, Tiwari HK. Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi. Natl Med J India. 1996;9:211-214.
19. Brown BA, Thach AB, Song JC, Marx JL, Kwun RC, Frambach DA. Retinopathy of prematurity: evaluation of risk factors. Int Ophthalmol. 1998;22:279-283.
20. Becker H, Lieser K, Heler K. Effect and correlation of various risk factors in the developmentl of retinopathy of prematurity: a retrospective study of 338 premature infants [article in German]. Klin Monatsbl Augenheilkd. 1990;196:456-459.
21. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005;34:169-178.
22. Akkoyun i, Oto S, Yilmaz G, et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS. 2006;10:449-453.
23. Shohat M, Reisner SH, Krikler R, Nissenkorn I, Yassur Y, Ben-Sira I. Retinopathy of prematurity: incidence and risk factors. Pediatrics. 1983;72:159-163.
24. Cooke RW, Clark D, Hickey-Dwyer M, Weindling AM. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr. 1993;152:833-836.
25. Karna P, Muttineni J. Angell L, Karmaus W Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr. 2005;5:18.
26. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Ophthalmologica. 2000;214:131-135.
27. Smith J, Spurrier N, Goggin M, Retinopathy of prematurity in a south Australian neonatal intensive care unit. Aust N Z J Ophthalmol. 1995;23:49-54.
28. Nodgaard H, Andreasen H, Hansen H, Sorensen HT. Risk factors associated with retinopathy of prematurity (ROP) in northern Jutland, Denmark 1990-1993. Acta Ophthalmol Scand. 1996;74:306-310.
29. Arroe M, Peitersen B. Retinopathy of prematurity: review of a seven-year period in a Danish neonatal intensive care unit. Acta Paediatr. 1994;83:501-505.
30. Fledelius HC. Rctinopathy of prematurity: clinical findings in a Danish County 1982-87. Acta Ophthalmol (Copenh). 1990;68:209-213.
31. Good WV, Hardy RJ, Dobson V, et al. The incidence and course of retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity Study. Pediatrics. 2005;116:15-23.
32. Reynolds JD, Hardy RJ, Kennedy KA, Spencer R, van Heuven WA, Fielder AR. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med. 1998;338:1572-1576.
33. Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol. 2004;18:130-134.
34. Jandeck C, Kellner U, Kossel H, Bartsch M, Versmold HT, Foerster MH. Retinopathy of prematurity in infants of birth weight > 2000 g after haemorrhagic shock at birth. Br J Ophthalmol. 1996;80:728-731.
35. Hutchinson AK, O'Neil JW, Morgan EN, Cervenak MA, Saunders RA. Retinopathy of prematurity in infants with birth weights greater than 1250 grams. J AAPOS. 2003:7:190-194.
36. Patz A, Hoeck LE, de la Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia: I. Nursery observations. Am J Ophthalmol. 1952;35:1248-1253.
37. Yu VY, Hookham DM, Nave JR. Retrolental fibroplasia - controlled study of 4 years' experience in a neonatal intensive care unit. Arch Dis Child. 1982;57:247-252.
38. Gallo JE, Jacobson L, Broberger U. Perinatal factors associated with retinopathy of prematurity. Acta Paediatr. 1993;82:829-834.
39. Saugstad OD. Oxygen and retinopathy of prematurity. Perinatol. 2006;26(suppl 1):S46-S50.
40. McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis. 2004;10:512-520.
41. Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci. 1995;36:2063-2070.
42. Liu PM, Fang PM, Huang CB, et al. Risk factors of retinopathy of prematurity in premature infants weighing less than 1600 g. Am J Perinatol. 2005;22:115-120.
43. Sacks LM, Schaffer DB, Anday EK, Peckham GJ, Delivoria-Papadopoulos M. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants. Pediatrics. 1981;68:770-774.
44. Hirano K, Morinobu T, Kim H, et al. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2001;84:F188-F193.
45. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion: iron load and retinopathy of prematurity. Eur J Pediatr. 1997;156:465-470.
46. Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol. 1998;116:601-605.